Clinical Trial Update: Treatment of Notalgia Paresthetica With Xeomin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Xeomin for Notalgia paresthetica has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Notalgia Paresthetica

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Innovaderm Research Inc. | Conditions: Notalgia Paresthetica | Phase 3 | Status: COMPLETED